Book contents
- The Essence of Analgesia and Analgesics
- The Essence of Analgesia and Analgesics
- Copyright page
- Contents
- Contributors
- 1 Introduction
- Section 1 Pain Definitions
- Section 2 Oral and Parenteral Opioid Analgesics
- Section 3 Neuraxial Opioid Analgesics
- Section 4 NSAIDs
- Section 5 Local Anesthetics
- Section 6 Anticonvulsant-Type Analgesics
- Section 7 NMDA Antagonists
- Section 8 Alpha-Adrenergic Analgesics
- Section 9 Antidepressants
- Section 10 Muscle Relaxants
- Section 11 Adjuvant Analgesics and Antiemetics
- Section 12 New and Emerging Analgesics
- 108 Overview: novel targets for new analgesics
- 109 Intranasal morphine
- 110 Intranasal ketamine
- 111 Inhaled fentanyl
- 112 Hydromorphone extended-release
- 113 Hydrocodone extended-release
- 114 Iontophoretic transdermal fentanyl
- 115 Tapentadol ER
- 116 Tamper-resistant opioids
- 117 Novel sustained-release analgesics
- 118 Extended-duration bupivacaine
- 119 Morphine-6-glucuronide
- 120 Neostigmine
- 121 Buprenorphine transdermal
- 122 Nicotine (transdermal)
- 123 Local anesthetic bone paste
- 124 Peripheral kappa agonists
- 125 Cannabinoid agonists
- 126 Peripheral cannabinoid receptor agonists
- 127 Injectable capsaicin
- 128 TRPV-1 ion channel blockers
- 129 Neramexane
- 130 Nociceptin
- 131 Anti-nerve growth factor
- Index
118 - Extended-duration bupivacaine
from Section 12 - New and Emerging Analgesics
Published online by Cambridge University Press: 06 December 2010
- The Essence of Analgesia and Analgesics
- The Essence of Analgesia and Analgesics
- Copyright page
- Contents
- Contributors
- 1 Introduction
- Section 1 Pain Definitions
- Section 2 Oral and Parenteral Opioid Analgesics
- Section 3 Neuraxial Opioid Analgesics
- Section 4 NSAIDs
- Section 5 Local Anesthetics
- Section 6 Anticonvulsant-Type Analgesics
- Section 7 NMDA Antagonists
- Section 8 Alpha-Adrenergic Analgesics
- Section 9 Antidepressants
- Section 10 Muscle Relaxants
- Section 11 Adjuvant Analgesics and Antiemetics
- Section 12 New and Emerging Analgesics
- 108 Overview: novel targets for new analgesics
- 109 Intranasal morphine
- 110 Intranasal ketamine
- 111 Inhaled fentanyl
- 112 Hydromorphone extended-release
- 113 Hydrocodone extended-release
- 114 Iontophoretic transdermal fentanyl
- 115 Tapentadol ER
- 116 Tamper-resistant opioids
- 117 Novel sustained-release analgesics
- 118 Extended-duration bupivacaine
- 119 Morphine-6-glucuronide
- 120 Neostigmine
- 121 Buprenorphine transdermal
- 122 Nicotine (transdermal)
- 123 Local anesthetic bone paste
- 124 Peripheral kappa agonists
- 125 Cannabinoid agonists
- 126 Peripheral cannabinoid receptor agonists
- 127 Injectable capsaicin
- 128 TRPV-1 ion channel blockers
- 129 Neramexane
- 130 Nociceptin
- 131 Anti-nerve growth factor
- Index
Summary
![Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'](https://static.cambridge.org/content/id/urn%3Acambridge.org%3Aid%3Abook%3A9780511841378/resource/name/firstPage-9780511841378c118_p471-475_CBO.jpg)
- Type
- Chapter
- Information
- The Essence of Analgesia and Analgesics , pp. 471 - 474Publisher: Cambridge University PressPrint publication year: 2010